Related Research Articles
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906).
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. BMS is one of the world's largest pharmaceutical companies, and is consistently ranked on the Fortune 500 list of the largest U.S. corporations. As of September 2020, it had the total revenue of $39.3 billion.
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has bearer shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the largest pharmaceutical company in the world, and the leading provider of cancer treatments globally.
Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Warner Chilcott was a company in the pharmaceutical industry based in Rockaway, New Jersey. It was primarily focused on women’s healthcare and dermatology. On October 1, 2013, the company was acquired by Actavis.
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, near Oxford, England.
Bausch Health Companies Inc. is a multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products.
Forest Laboratories was a company in the pharmaceutical industry incorporated in Delaware, with its principal office in New York City. It was known for licensing European pharmaceuticals for sale in the United States. On July 1, 2014, the company was acquired by Actavis.
Teva Pharmaceutical Industries Ltd., also known as Teva Pharmaceuticals, is a global pharmaceutical company with headquarters in Petah Tikva, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. In 2020, Teva Pharmaceuticals was the second largest generic drug manufacturer and the eighteenth largest pharmaceutical company in the world.
Actavis Generics is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. It is largest Pharma Company in India and 4th largest in the world. The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anti-cancers, steroids, peptides, sex hormones, and controlled substances.
Linaclotide, is a drug used to treat irritable bowel syndrome with constipation and chronic constipation with no known cause. It has a black box warning about the risk of serious dehydration in children in the US; the most common adverse effects in others are gastrointestinal.
Pharmasset Inc. was a pharmaceutical company based in Princeton, New Jersey in the United States. The company develops antiviral drugs for HIV, hepatitis B, and hepatitis C. In November 2011, Pharmasset was acquired by Gilead for $11.2 billion.
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.
Jazz Pharmaceuticals plc is a biopharmaceutical company based in Ireland. It was founded in 2003. One of the company's most significant products is the United States Food and Drug Administration (FDA) approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA).
Kite Pharma is an American biotechnology company that develops cancer immunotherapy products, with a primary focus on genetically-engineered autologous T cell therapy with chimeric antigen receptors (CAR-T). Based in Santa Monica, California, it is a subsidiary of Gilead Sciences.
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.
Royalty Pharma is a biopharmaceutical company based in New York City that purchases economic interests in marketed and late stage biopharmaceutical products from life sciences organizations. Royalty Pharma funds innovation in life sciences both directly and indirectly: directly when it partners with life sciences companies to co-develop and co-fund products in late-stage clinical trials, and indirectly when it acquires existing royalty interests from the original innovators.
References
- ↑ "Our Legacy". Adare Pharma Solutions. Retrieved 13 December 2020.
- ↑ "Axcan Announces Completion of Transaction With TPG Capital" (Press release). Marketwired. February 25, 2008.
- ↑ "The Newly Combined Axcan and Eurand Announce Name Change to Aptalis" (Press release). PR Newswire. May 6, 2011. Archived from the original on March 3, 2018. Retrieved March 2, 2018.
- ↑ "Aptalis Pharma Announces FDA Approval of 3,000 Lipase-Unit Strength of ZENPEP" (Press release). Marketwired. June 17, 2011.
- ↑ "Aptalis Pharma Announces Agreement to Market RECTIV™ in the U.S." (Press release). Marketwired. January 9, 2012.
- ↑ "Aptalis Pharma Announces FDA Approval of NDA for Oral Powder Formulation of Viread®, Co-Developed With Gilead Sciences, Inc" (Press release). Marketwired. January 18, 2012.
- ↑ "Aptalis Pharma™ Launches PYLERA® 10 Day Therapy PAK in the United States" (Press release). Marketwired. September 3, 2013.
- ↑ "Aptalis to be Acquired by Forest Laboratories for $2.9 Billion" (Press release). Business Wire. January 8, 2014.
- ↑ Humer, Caroline (January 7, 2014). "Forest Labs to buy Aptalis from TPG for $2.9 billion". Reuters .
- ↑ "Aptalis Holdings officially withdraws IPO following announcement of its acquisition by Forest Labs". NASDAQ . January 31, 2014.
- ↑ "TPG Completes Acquisition of Aptalis Pharmaceutical Technologies, Company Renamed Adare Pharmaceuticals" (Press release). Business Wire. April 2, 2015.
- ↑ "Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals". 30 September 2020. Retrieved 13 December 2020.
| General | |
|---|---|
| National libraries | |
